Ligand Pharmaceuticals

NASDAQ: LGND · Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT

Ligand Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-486.05 23.69 -215.9 44.96
PEG Ratio
4.53 -0.02 1.98 -0.02
PS Ratio
11.73 9.41 5.74 9.27
PB Ratio
2.36 1.76 1.89 3.13
P/FCF Ratio
20.58 -289.19 9.40 36.68
P/OCF Ratio
20.19 24.92 8.17 32.60
OCF/S Ratio
0.58 0.38 0.70 0.28
Debt / Equity Ratio
0.01 0.01 0.15 0.41
Quick Ratio
8.55 12.72 2.53 10.50
Current Ratio
8.93 14.15 2.67 11.15
Asset Turnover
0.18 0.17 0.26 0.21
Interest Coverage
-7.44 18.20 -14.18 4.02
Return on Equity
n/a 0.07 -0.01 0.07
Return on Assets
n/a 0.07 -0.01 0.04
Return on Invested Capital
0.04 0.01 n/a 0.08
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.93 0.73 0.73 0.78
Net Profit Margin
-0.02 0.40 -0.03 0.21
Pretax Profit Margin
0.02 0.48 0.18 0.17
Operating Profit Margin
-0.14 0.09 -0.13 0.28
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.24 0.77 0.28 0.48